GSK Sues Lupin Over ANDA For HIV Drug Combivir

Law360, New York (September 2, 2008, 12:00 AM EDT) -- GlaxoSmithKline PLC is suing Lupin Pharmaceuticals Inc. for its efforts to market a generic version of Combivir, a combination drug used to treat HIV patients.

In a complaint filed Friday in the U.S. District Court for the District of Delaware, the pharmaceutical giant claimed Lupin's abbreviated new drug application with the U.S. Food and Drug Administration infringed GSK's patent.

Lupin notified GSK on July 17 that it had submitted an application to make a product containing 150 mg of lamivudine and 300 mg of zidovudine, the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.